Research Article
Impact of Interstitial Pneumonia on the Survival and Risk Factors Analysis of Patients with Hematological Malignancy
Table 3
Univariate comparisons between IP patients with and without death.
| | Variables | Alive group
() | Death group
() | value |
| | Male sex | 16 | 25 | 0.391 | | Age | 40.0 ± 24.9 | 55.7 ± 24.8 | 0.023 | | Underlying hematological malignancy | | | 0.012 | | Non-Hodgkin lymphoma | 8 | 18 | | | Hodgkin lymphoma | 5 | 0 | | | Leukemia | 6 | 19 | | | Multiple myeloma | 2 | 3 | | | Hemoglobin (g/dL) | 11.6 ± 2.4 | 9.6 ± 1.7 | 0.001 | | Leukocyte count(/uL) | 6210 ± 3600 | 10948 ± 10671 | 0.540 | | Platelet count (103/uL) | 222476 ± 111744 | 124050 ± 114500 | 0.002 | | C-reactive protein (mg/dL) | 7.94 ± 9.5 | 9.6 ± 1.7 | 0.311 | | Arterial pO2 (mmHg) | 83.6 ± 12.9 | 78.9 ± 11.8 | 0.169 | | Arterial pCO2 (mmHg) | 36.7 ± 4.1 | 34.2 ± 4.1 | 0.026 |
|
|
IP: interstitial pneumonia.
|
